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Atomic force microscopyLysozyme and antimicrobial peptides are key factors of the humoral immune response in insects. In the pre-
sent work lysozyme and anionic defense peptide (GMAP2) were isolated from the hemolymph of the greater
wax moth Galleria mellonella and their antibacterial activity was investigated. Adsorption of G. mellonella ly-
sozyme on the cell surface of Gram-positive and Gram-negative bacteria was demonstrated using immuno-
blotting with anti-G. mellonella lysozyme antibodies. Lysozyme effectively inhibited the growth of selected
Gram-positive bacteria, which was accompanied by serious alterations of the cell surface, as revealed by
atomic force microscopy (AFM) imaging. G. mellonella lysozyme used in concentrations found in the hemo-
lymph of naive and immunized larvae, perforated also the Escherichia coli cell membrane and the level of
such perforation was considerably increased by GMAP2. GMAP2 used alone did not perforate E. coli cells
nor inﬂuence lysozyme muramidase activity. However, the peptide induced a decrease in the turgor pressure
of the bacterial cell. Moreover, in the samples of bacteria treated with a mixture of lysozyme and GMAP2 the
sodium chloride crystals were found, suggesting disturbance of ion transport across the membrane leading to
cell disruption. These results clearly indicated the synergistic action of G. mellonella lysozyme and anionic
peptide 2 against Gram-negative bacteria. The reported results suggested that, thanks to immune factors con-
stitutively present in hemolymph, G. mellonella larvae are to some extent protected against infection caused
by Gram-negative bacteria.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial or defense peptides are key factors of the innate im-
mune response against invading pathogens in animals. Most antimicro-
bial peptides are small, amphipathic, cationic molecules. According to
their amino acid sequence and secondary structure, they are usually
classiﬁed into three classes: (i) alpha-helical linear peptides without
cysteine residues, e.g. cecropins, (ii) peptides stabilized by disulﬁde
bridges, e.g.defensins, and (iii) peptideswith overrepresentation of cer-
tain single amino acid, as e.g. proline-rich peptides. In majority of anti-
microbial peptides the relatively high content of positively charged
arginine and lysine residues facilitates interaction with anionic surface
of pathogen cells. The interactionwithmembrane phospholipids is pos-
sible thanks to the presence of both hydrophobic as well as hydrophilic
domains in the antimicrobial peptide molecules. Several modes of+48 81 537 59 01.
Cytryńska).
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rights reserved.interaction with microbial membranes have been proposed for
cationic defense peptides: (i) carpet-like model, (ii) barrel-stave
model, (iii) toroidal pore model, and (iv) aggregate formation model.
Binding of the cationic peptides to the phospholipid molecules present
in a microbial membrane can induce formation of transmembrane
pores of different structures, changes in permeability, and even disrup-
tion of themembrane. Besides cell membrane phospholipids, outer sur-
face lipids and outer membrane as well as integral membrane proteins
can be the major targets for antimicrobial peptides. Some peptides can
also traverse across the cellmembrane, penetrate the pathogen cell and,
after binding to DNA, RNA or heat shock proteins, they can disturb the
proper functioning of the cell [1–10].
Among antimicrobial peptides the examples of anionic molecules
have also been described. Defense peptides with such negative net
charge were ﬁrst isolated from ovine pulmonary surfactant and named
surfactant-associated anionic peptides (AP). They are small molecules
(molecular weight 720–825 Da) containing homopolymeric regions of
5 to 7 aspartic acid residues. The peptides require zinc ions formaximum
antimicrobial activity, however, to date, the mechanism of their bacteri-
cidal action is not known. One can speculate that the anionic peptides
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tion of the cell content [11–13]. Examples of anionic defense peptides
have also been characterized in invertebrates. From the hard tick
Amblyomma hebraeum, a defensin-like peptide of pI 4.44 exhibiting
activity against Escherichia coli and Staphylococcus aureus was iso-
lated [14]. Similarly, an anionic defensin-like peptide with predicted pI
4.12was described in the lepidopteran insect, Bombyxmori [15]. Two an-
ionic defense peptides, named anionic peptides 1 and 2 (GMAP1 and
GMAP2), were discovered among the defense peptides found in the he-
molymph of the greater wax moth Galleria mellonella. GMAP2 is 60
amino acids long, 6.98 kDa peptide of pI 4.79. The sequence of this pep-
tide contains 8 residues of glutamic acid, 3 residues of aspartic acid and
does not contain cysteine, histidine, arginine nor tryptophan. The amino
acid sequence of GMAP2 is unique and to date, no signiﬁcantly similar
sequences of other peptides nor proteins have been found. Interesting-
ly, GMAP2 is present constitutively in hemolymph of non-immunized
G. mellonella larvae in a relatively high concentration estimated as
11.7 μM (±3.17). The peptide is moderately active against selected
Gram-positive bacteria and yeasts in vitro [16,17].
Another important component of the insect humoral immune re-
sponse is lysozyme. Lysozymes have been isolated and studied from
many insect species, including representatives of Lepidoptera, Diptera,
Coleoptera as well as Hymenoptera [18–30]. According to their amino
acid sequence and other physico-chemical properties,most of the insect
lysozymes belong to c-type family of lysozymes [31].
The lysozyme of the lepidopteran G. mellonella which contains 121
amino acids, has a predictedmolecular weight 14027 Da and isoelectric
point pI=9.28 (SWISS-PROT data bank: locus LYC_GALME, accession
P82174). The antibacterial and antifungal activity of G. mellonella lyso-
zyme was described earlier [26,32]. It was demonstrated that, similarly
to some other lepidopteran lysozymes, G. mellonella lysozyme exhibited
a lowactivity against selectedGram-negative bacteria (E. coliK112, E. coli
DH5α, Salmonella paratyphi A, S. choleraesuis) [26], in addition to its high
anti-Gram-positive bacteria activity. Lysozyme in G. mellonella is synthe-
sized constitutively and is present in the hemolymph of naive larvae in
the concentration of 0.76 μM (±0.17) [17]. Based on the experiments
performed using egg white lysozyme (EWL), it was suggested that lyso-
zyme could act synergistically with certain G. mellonella antimicrobial
peptides and proteins against Gram-negative bacteria [33]. It was also
demonstrated that EWL activity against M. luteus increased in the pres-
ence of apolipophorin III [34], whereas E. coli became more sensitive to
attacins, cecropins and insect defensins in the presence of lysozyme
[35,36].
The constitutive presence of high GMAP2 concentrations in
G. mellonella hemolymph together with its relatively low antimicrobi-
al activity prompted us to investigate the effects of this defense peptide
on the antibacterial activity of G. mellonella lysozyme. X-ray analysis,
imaging by atomic force microscopy (AFM) and scanning electron mi-
croscopy (SEM) were used to characterize the alterations caused by
the compounds studied in the bacteria cell surface and morphology.
Moreover, AFMwas used to determine the inﬂuence of G. mellonella ly-
sozyme andGMAP2 on nanomechanical properties of the bacterial cells,
such as elasticity and adhesive forces.
2. Materials and methods
2.1. Bacterial strains and culture conditions
Gram-positive bacteria (Bacillus circulans ATCC 61, Corynebacterium
avis, Listeria monocytogenes,Micrococcus luteus ATCC 10240, Rhodococcus
aqui, Sarcina lutea, S. aureus ATCC 25922) were grown at 28 °C, whereas
Gram-negative bacteria (E. coli D31, E. coli JM83, Klebsiella pneumoniae,
Pseudomonas aeruginosa H3, Salmonella typhimurium LT2, Sinorhizobium
meliloti) were cultured at 37 °C (with exception of S. melilotiwhich was
grown at 28 °C) in 2.5% Luria–Bertani (LB) medium. Bacteria in the loga-
rithmic phase of growth were used during the experiments.2.2. Insect immune challenge, hemolymph collection, and preparation of
methanolic extracts
Larvae of the greaterwaxmothG.mellonella (Lepidoptera: Pyralidae)
were reared on a natural diet—honeybee nest debris at 30 °C in thedark.
Last instar larvae (250–300 mg in weight) were used throughout the
study.
For the immune challenge, the larvae were pierced with a needle
dipped into a pellet containing live cells of E. coli D31 andM. luteus and
the hemolymph was collected 24 h after the immunization. The hemo-
lymph was collected into sterile and chilled Eppendorf tubes containing
a few crystals of phenylthiourea (PTU) to prevent melanization, as de-
scribed earlier [37]. The hemocyte-free hemolymph was obtained by
centrifugation at 200×g for 5 min to pellet the hemocytes and the super-
natant was subsequently centrifuged at 20,000×g for additional 15 min
at 4 °C to pellet the cell debris. The cell-free hemolymph was stored at
−20 °C until needed. Methanolic extracts containing antimicrobial
peptides and proteins below 30 kDa were prepared from the cell-
free hemolymph as described earlier [16].2.3. Puriﬁcation of G. mellonella lysozyme and anionic defense peptide
G. mellonella lysozyme and AP2 were puriﬁed from the immune
hemolymph extract using a modiﬁed technique described in our pre-
vious study [16]. Brieﬂy, the hemolymph extract, deprived of lipids and
freeze-dried, was dissolved in 0.1% triﬂuoroacetic acid (TFA) and sub-
jected to the HPLC chromatography using a Supelcosil LC-18-DB
4.6 mm×250 mm column (Sigma-Aldrich-Fluka-Supelco Company, St.
Louis,MO, USA), two buffer set, A: 0.1% TFA (v/v), B: 0.07% TFA, 80% ace-
tonitrile (v/v), a linear gradient from 36 to 68% of buffer B over 30 min
and 1 ml/min ﬂow rate. The collected fractions were freeze-dried, redis-
solved in water, subjected to SDS-PAGE electrophoresis [38], electro-
blotted onto a polyvinylidene diﬂuoride (PVDF) membrane, stained
with Coomassie Brillant Blue R-250 and then identiﬁed by N-terminal
amino acid sequencing on Procise 491 (Applied Biosystems, Foster City,
CA, USA). The results of the electrophoresis and sequencing proved
that anionic peptide 2 was obtained in a pure form. On the other hand,
the slightly contaminated fraction containing lysozymewas additionally
puriﬁed by gel ﬁltration chromatography on a Superdex Peptide 10/300
GL column (Pharmacia Biotech, Uppsala, Sweden), using 0.1% TFA sup-
plemented with 40% (v/v) acetonitrile as mobile phase and 0.4 ml/min
ﬂow rate. The puriﬁed proteins and peptideswere lyophilized and stored
at−80 °C. For the experiments, they were redissolved in sterile deion-
ized water.2.4. Adsorption of lysozyme on the bacterial cell surface
Adsorption ofG.mellonella lysozyme on bacterial cellswas performed
as described in our previous paper [39]. In brief, the suspensions of bac-
teria (200 μl, OD600=1.0) growing overnight in a liquid LB medium
were centrifuged at 1600×g at 4 °C for 10 min. Obtained bacterial pellet
was suspended in 20 μl of amixture of 0.9%NaCl and 20% acetic acid (1:1,
v/v). After 5-min incubation at room temperature, 100 μl of 1 M Tris–HCl
pH 8.2 was added to neutralize the acidic pH. After centrifugation, the
pellet was suspended in 20 μl of 10 mM Tris–HCl pH 8.2. The bacterial
suspension was incubated without and in the presence of hemolymph
extracts (5 μg of total protein) for 5 min at 30 °C and centrifuged. The
pellet containing proteins adsorbed on the bacterial cells was washed
twice in 50 μl of sterile water and suspended in 20 μl of 0.5 M
ammonium formate pH 6.4. Laemmli sample buffer was added to the
pellet and to the obtained supernatant containing proteins that did
not adsorb on the bacterial surface. The samples were subjected to
Tris-glycine SDS-PAGE [40] and subsequent immunoblotting with anti-
bodies against G. mellonella lysozyme.
Fig. 1. Growth inhibition of bacteria by G. mellonella lysozyme. The bacteria were incu-
bated without (control) or in the presence of lysozyme (0.015 μM) for 1.5 h. Then the
optical density of the bacterial suspensions was determined at 600 nm. The diagram
presents results±SD of three independent experiments each performed in triplicate.
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The samples subjected to 13.8% Tris-glycine SDS-PAGEwere electro-
blotted onto PVDFmembranes (Millipore) for 90 min at 350 mA, rinsed
in TBS (10 mMTris–HCl pH 7.4, 0.9% NaCl) and blocked in 3% skimmilk
in TBS For lysozyme identiﬁcation, the membranes were then probed
with rabbit polyclonal antibodies (1:1000) to G. mellonella lysozyme
(a generous gift from Prof. I.H. Lee, Department of Life Science, Hoseo
University, South Korea). Alkaline phosphatase-conjugated goat anti-
rabbit IgG (1:30,000) was used as second antibody and the immunore-
active bands were visualized by incubation with p-nitro blue tetrazoli-
um chloride and 5-bromo-4‐chloro‐3‐indolyl phosphate (BCIP/NBT).
2.6. Antibacterial activity of G. mellonella lysozyme
2.6.1. Measurement of the optical density of the live bacteria suspension
Ten microliters of suspension of live log-phase bacterial cells in LB
medium (OD600=0.2) was incubated without (control) or in the pres-
ence of G. mellonella lysozyme (ﬁnal concentration 0.015 μM) for 1.5 h
at 28 °C. After incubation, the optical density of the bacterial suspen-
sions was determined at 600 nm.
2.6.2. Bacterial membrane permeabilization assay
The ability of the compounds studied to perforate the Gram-negative
bacteria membranewas determined using the E. coli JM83 strain bearing
plasmid pCH110 (Pharmacia-Amersham, Piscatway, NJ, USA) encoding
constitutively synthesized cytoplasmic β-galactosidase and ampicilin re-
sistance [41]. G. mellonella lysozyme, GMAP2, andmixtures of both com-
pounds in 20 mMphosphate buffer pH 6.8 (23 μl) were preincubated for
15 min at 37 °C in Eppendorf tubes. Then, 2 μl of live mid-logarithmic
phase cells suspension (5×105 CFU) in the same buffer was added and
the sampleswere incubated for 45 min at 37 °C (the ﬁnal concentrations
of lysozyme — 0.5 μM and 5.0 μM; AP2 — 0.5 μM and 5.0 μM). Next,
220 μl of 20 mM HEPES/150 mM NaCl buffer pH 7.5 and 5 μl of the
β-galactosidase colorimetric substrate (50 mM aqueous solution of
p-nitrophenyl-β-D-galactopyranoside) were added. The samples were
transferred into the wells of a ﬂat-bottom polyethylene 96-well plate
and vortexed; after 90 min of incubation at 37 °C absorbance, propor-
tional to the amount of released β-galactosidase, were measured at
405 nm. Two types of the control sampleswere prepared: (i) live bacte-
ria and (ii) dead bacteria (after lysis using EWL 3 mg/ml and 0.1% Triton
X-100) incubated without peptide addition. The perforation level of the
dead bacteria was assumed as 100%. All assays were performed in
triplicate.
2.7. AFM and SEM imaging of bacterial cells
2.7.1. Preparation of bacterial samples
One hundredmicroliters of suspension containing log-phase bacterial
cells (OD600=0.2) cultured in the LBmediumwas centrifuged at 8000 ×g
for 10 min at 4 °C. The cells were gently washed with 100 μl of sterile
20 mM phosphate buffer pH 6.8 and centrifuged as described. Then, the
bacteria were incubated for 1.5 h without (control) and in the presence
of puriﬁed G. mellonella lysozyme (ﬁnal concentration 0.015 μM for the
Gram-positive bacteria; 1.0 μM and 5.0 μM for the Gram-negative
bacteria) at 28 °C in 20 mM phosphate buffer pH 6.8 in a ﬁnal vol-
ume of 130 μl (in triplicate). E. coli JM83 and K. pneumoniae were also
treated with GMAP2 (the ﬁnal concentrations 1.0 μM and 5.0 μM) and
with a mixture of lysozyme and GMAP2 (lysozyme and GMAP2 molar
ratio 1:1). For determination of a neutral protein effect, the bacteria
were incubated with bovine serum albumin (BSA, Sigma; dissolved in
sterile deionised water) under the same conditions. After incubation,
the bacterial suspensions were centrifuged as described above. The bac-
terial pellets were gently washed once with 150 μl of sterile 20 mM
phosphate buffer pH 6.8 and then twice with 100 μl of apyrogenic
water. After ﬁnal centrifugation, the bacteria were suspended in 5 μl ofapyrogenicwater. For AFM, the sampleswere then applied on the surface
of freshly cleavedmica discs and allowed to dry overnight at 28 °C before
imaging.
For SEM, the samples were ﬁxed with 4% glutaraldehyde in 0.1 M
phosphate buffer pH 7.0. Then, the cells were stainedwith 1.5% osmium
tetroxide in the same buffer for 30 min at room temperature. After-
wards, the cells were dehydrated stepwise in a graded series of acetone,
allowed to dry overnight and sputter-coated with gold. Some probes
were prepared for SEM after being examined by AFM. For this purpose,
the dry samples on mica discs were sputtered with an ultra thin gold-
palladium ﬁlm.
2.7.2. AFM imaging
The alterations in the bacterial cell surface caused by G. mellonella ly-
sozyme and GMAP2were imaged by AFM (Analytical Laboratory, Faculty
of Chemistry, UMCS, Lublin, Poland). Allmeasurements in the contact and
tapping operation modes were carried out using a NanoScope V AFM
(Veeco,USA) equippedwithNanoScope8.10 software and apiezoscanner
of amaximum scan range of 150 μm×150 μm. For the contactmode a sil-
icon nitride tip with a spring constant of 0.06 N/m, whereas for the tap-
ping mode a rectangular Si cantilever/tip (Veeco, USA) with a spring
constant of 20–80 N/m and resonance frequency of 300 kHz were used.
The resolution of the scans obtained was 256×256 pixels. The topogra-
phy and amplitude/deﬂection images were obtained simultaneous-
ly. Three ﬁelds on each mica disc were imaged. The data were analyzed
with WSxM 5.0 software (Nanotec, Spain). The roughness values were
measured over the entire bacterial cell surface on 600×600 nm areas.
The average surface root-mean-square (RMS) roughness of the cells
was calculated from ten ﬁelds estimated during two independent
experiments.
For estimation of G. mellonella lysozyme and GMAP2 inﬂuence on
bacterial cells elasticity and adhesion properties, Young's modulus
and adhesion to the AFM tip were determined, respectively. The
force measurements were performed in “PeakForce QNM” operation
mode using a silicon tip on nitride lever, SCANASYST-AIR, with a
spring constant of 0.4 N/m (Veeco, USA). The data were analyzed
with Nanoscope Analysis ver. 1.40 software (VEECO, USA).
2.7.3. SEM imaging
The alterations caused by G. mellonella lysozyme and GMAP2 (the
ﬁnal concentrations 1.0 μM) on the cell surface of the Gram-negative
bacteria tested were also imaged by scanning electron microscopy.
The samples were examined under a VEGA 3 LMUmicroscope (Tescan,
Czech Republic) (Institute of Biology and Biochemistry, Faculty of Biol-
ogy and Biotechnology, UMCS, Lublin, Poland).
Fig. 2. The effect of G. mellonella lysozyme on Bacillus circulans andMicrococcus luteus cells. The bacteria were incubated without (control) or in the presence of lysozyme (0.015 μM)
for 1.5 h and then imaged using AFM. Topography and amplitude images of the bacterial cells are presented. The black and white arrows in the B. circulans images indicate the gran-
ular structures appearing on the surface of the lysozyme-treated cells and the amorphous material present around the cells, respectively. The black and white arrows in theM. luteus
images indicate deep concavities appearing on the surface of the lysozyme-treated cells and the “cell ghosts”, respectively.
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by AFM were performed using a FEI Quanta 3D FED scanning electron
microscope equipped with an EDS detector (Analytical Laboratory, Fac-
ulty of Chemistry, UMCS, Lublin, Poland). The bacteria onmica foil weresputtered with an ultra thin gold-palladium ﬁlm. The pictures of the
bacterial topography were taken under high vacuum conditions at
30 kV accelerating voltage. An ETD (SE) detector was used to collect
the signals from the scattered electrons.
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The elemental analysis of randomly selected points on the observed
by AFM rectangular structures as well as the images on the bacterial sur-
face (control) was performed under FEI Quanta 3D FEG scanning electron
microscope (Analytical Laboratory, Faculty of Chemistry, UMCS, Lublin,
Poland). An imaging under SEMwas performed after sputtering the sam-
ples with a thin gold-palladium ﬁlm. Energy dispersive X-ray (EDX) mi-
croanalysis was made using a silicon drift detector (SDD) operating at
30 kV acceleration voltage. The microanalysis was carried out without
any shadowing and the concentrations of the elements were deter-
mined using the standardless method. A composition of the elements
in the rectangular structureswas calculated on the basis of the differen-
tial analysis of spectra obtained for the structures and the control areas.
2.9. Interaction between molecules of G. mellonella lysozyme and GMAP2
To elucidate the formation of an eventual intermolecular complex the
solutions of lysozyme and GM anionic peptide 2 in 50 mM sodium phos-
phate pH 7.4, 0.15 M NaCl were mixed together at 1:1 or 1:5 molar pro-
portions. After incubation for 1 h at room temperature both mixtures
were then analyzed by size exclusion chromatography on Superdex Pep-
tide 10/300 GL column (GE Healthcare, USA) equilibrated in 0.1 M sodi-
um phosphate pH 7.4 at 0.4 ml/min ﬂow rate.
2.10. Other methods
The protein concentration was estimated by the Bradford method
using BSA as a standard [42]. Polyacrylamide gel electrophoresis ofFig. 3. Analysis of the alterations in B. circulans andM. luteus cell surfaces after incubation wi
ence of lysozyme (0.015 μM) for 1.5 h and then imaged using AFM. An analysis of contact mo
ness analysis of the square area marked in (a); (d) section proﬁles corresponding to black/proteins was performed by 13.8% Tris-glycine SDS-PAGE according
to Laemmli [40]. The peptides were resolved by 16.5% Tris-tricine
SDS-PAGE according to Schägger and von Jagow [38]. The data are pres-
ented asmeans±standard deviation (SD) for at least three experiments.
In order to compare two means, statistical analysis was performed by
Student's t-test.3. Results
3.1. Antibacterial activity of G. mellonella lysozyme
The activity of puriﬁed G. mellonella lysozymewas tested against se-
lected Gram-positive (B. circulans, M. luteus, and S. aureus) and Gram-
negative (E. coli, K. pneumoniae, and S. typhimurium) bacteria. After
1.5 h incubation, lysozyme in a concentration of 0.015 μM inhibited
growth of all Gram-positive bacteria. B. circulanswas themost sensitive
to lysozyme action (growth inhibition in about 60%). In contrast, the
Gram-negative bacteria tested under the same conditionswere not sen-
sitive to G. mellonella lysozyme (Fig. 1).
The decrease in the optical density of the Gram-positive bacteria cul-
tures caused by 0.015 μM G. mellonella lysozyme was accompanied by
evident alterations in the bacterial cell surface. The alterations in the
B. circulans and M. luteus cell surfaces were imaged using atomic force
microscopy. B. circulans control cells were smooth surfaced and rod-
shaped (Figs. 2, 3). After exposure toG.mellonella lysozyme, the cell sur-
face became highly granularwith irregular grooves (50 nmdepth; diam-
eter about 200 nm). Cells that were still rod-shapedwere surrounded by
an amorphous material, probably the remains of the dead cells.M. luteus
control cells were regularly round and had a smooth cell surface (Figs. 2,th G. mellonella lysozyme. The bacteria were incubated without (control) or in the pres-
de images of the whole cells is presented. (a) topography and (b) 3D images; (c) rough-
white lines in (a).
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they exhibited deep concavities (70 nm depth, diameter about 500 nm)
formed usually in the central part of the cell. “Cell ghosts”were also no-
ticed. The cell surface alterations detected were conﬁrmed by analysis of
cell surface roughness. The roughness root‐mean‐square (RMS) values
for control B. circulans andM. luteus were estimated as 24.46 (±10.62)
and 44.48 (±16.52), respectively. In contrast, RMS roughness values
for lysozyme-treated B. circulans and M. luteus were calculated as 38.88
(±17.00; p=0.004) and 35.07 (±9.37; p=0.045), respectively.
3.2. Adsorption of G. mellonella lysozyme to the bacterial cell surface
In our previous study, we demonstrated that G. mellonella
apolipophorin III, a protein involved in the insect immune response,
bound to a cell surface of different bacteria [39]. Since it is well known
that lysozyme is involved in the antimicrobial activity of insect hemo-
lymph, we tested G. mellonella lysozyme binding to a cell surface of dif-
ferent Gram-positive and Gram-negative bacteria. The bacteria were
incubatedwith aG.mellonellahemolymphextract (5 μg of total protein)
containing lysozyme and the proteins adsorbed on the cell surfacewere
analyzed by SDS-PAGE and, after electrotransfer onto the PVDF mem-
brane, by immunoblotting with anti-G. mellonella lysozyme antibodies
(Fig. 4). The analysis revealed that G. mellonella lysozyme bound to
the cell surface of all Gram-positive as well as Gram-negative bacteria
tested.
3.3. Permeabilization of the Gram-negative bacteria membrane by
G. mellonella lysozyme
The immunoblotting analysis revealed that G. mellonalle lysozyme
adsorbed not only to the cell surface of the Gram-positive bacteria butFig. 4. Binding of G. mellonella lysozyme to the bacterial cell surface. The bacteria were incu-
bated with the hemolymph extracts (5 μg of the total protein) as described in Material and
methods. The proteins eluted from the bacterial surface (c), present in supernatant (b), and
total extract proteins (a, control)were then resolvedbyTris-glycine SDS-PAGE, electroblotted
onto Immobilon membranes and probed with anti-lysozyme antibodies. Fragments of the
membranes presenting lysozyme recognized by the antibodies are demonstrated. Lysozyme
that bound to the bacterial cells (c) is additionally marked by the arrows.also to the cell surface of the Gram-negative ones. This prompted us
to investigate its possible role in the ﬁght against Gram-negative bacteria
in insects. In these experiments, the level of cell membrane perforation
in E. coli JM83 was estimated based on the level of activity of
β-galactosidase released from the damaged cells (Fig. 5). Prior
to β-galactosidase activitymeasurements, the bacteriawere incubated
in the presence of lysozyme in the concentrations 0.5 μM and 5.0 μM,
reﬂecting lysozyme concentrations in non-immune and immune hemo-
lymph of G. mellonella, respectively [17]. Moreover, the bacteria were in-
cubated with GMAP2 in the concentration 5.0 μM. The effect of GMAP2
on the level of E. colimembrane perforation by lysozyme was also stud-
ied. As presented in Fig. 5, the bacteria treatedwith 0.5 μMand5.0 μMly-
sozyme exhibited a perforation level of 4.9% and 21.6%, respectively,
indicating that G. mellonella lysozyme could permeabilize also Gram-
negative bacteria membranes. Interestingly, when the bacteria were in-
cubated with 5.0 μM lysozyme and GMAP2, the perforation level was
considerably higher (41.3%),whereasGMAP2 alone did not permeabilize
E. coli cells. Moreover, treatment of the bacteria with a mixture of 5 μM
GMAP2 and 0.5 μM lysozyme increased the perforation level almost to
that caused by 5.0 μM lysozyme alone (16.3% and 21.6%, respectively),
indicating that the concentrations of both compounds in non-immune
hemolymph could be high enough to permeabilize and ﬁnally effectively
kill the bacterial cells (Fig. 5).
It was studied also if the direct formation of an intermolecular
complex could explain the observed effect of GMAP2 on lysozyme
permeabilizing activity. To elucidate this possibility, the size exclusion
chromatography of the preincubated mixtures of both compounds was
performed as described in Materials and methods. The obtained results
were negative, no additional peak of the complex was observed, while
both the heights as well as the retention times of lysozyme and GMAP2
peaks were identical to those ones observed in case of chromatographic
separations of individual molecules (data not shown).
3.4. The effect of G. mellonella lysozyme and anionic peptide 2 on the cell
surface of Gram-negative bacteria
After incubation in the presence of lysozyme (5.0 μM) and AP2
(5.0 μM), E. coli JM83 cells were imaged using AFM, which allowed
analyses of the alterations in the bacterial cell surface caused by the
compounds studied (Figs. 6, 7). The control and BSA-treated cells
were rod-shaped and covered with relatively regular, small granular
structures; however, some cells exhibited additional long ﬂat grooves
on the surface (Figs. 6, 7). The RMS roughness values for the control
and BSA-treated cells were calculated as 26.12 (±12.30) and 34.84
(±12.28), respectively. When the bacteria were incubated in theFig. 5. The effect ofG.mellonella anionic defense peptide 2 on the level of perforation of E. coli
cells causedby lysozyme. Thebacteriawere incubatedwithout or in thepresenceof lysozyme
andGMAP2asdescribed inMaterial andmethods. Then theβ-galactosidase colorimetric sub-
strate was added and the perforation level was determined by measuring absorbance at
405 nm. The perforation level of the dead and live bacteria incubated without any addition
was treated as 100% and 0%, respectively. The concentrations of the compounds are given
below the diagram. The diagrampresents the results±SDof three independent experiments
each performed in triplicate.
Fig. 6. The effect of G. mellonella lysozyme (5.0 μM) and anionic peptide 2 (5.0 μM) on E. coli cells. The bacteria were incubated without (control) or in the presence of lysozyme
(5.0 μM), anionic peptide 2 (5.0 μM) or the combination of both compounds as described in Materials and methods and then imaged by AFM. (A) Topography and deﬂection images
of the bacterial cells are presented. The white arrows indicate disordered cellular debris of the lysozyme-treated bacteria. The black arrows mark poorly pronounced contours of the
GMAP2-exposed cells. The white and black arrowheads indicate damaged cells and regular extracellular crystals, respectively, visible after incubation of bacteria with the combi-
nation of lysozyme and GMAP2. (B) Topography images taken from two randomly selected areas on the mica disk (upper panels) and section proﬁles corresponding to the lines in
the images (bottom panels) are presented (magniﬁcation 135,000×). The black arrows mark regular extracellular crystals observed after incubation of bacteria with the combina-
tion of lysozyme and GMAP2.
Fig. 7. The alterations in the E. coli cell surface caused by G. mellonella lysozyme (5.0 μM) and anionic peptide 2 (5.0 μM). The bacteria were incubated without (control) or in the
presence of lysozyme (5.0 μM), anionic peptide 2 (5.0 μM) or the combination of both compounds as described in Materials and methods and then imaged by AFM. The 3D, topog-
raphy, amplitude and phase images of the bacterial cell surface taken from two randomly selected areas on the mica disk are presented (magniﬁcation 135,000×). The white arrows
indicate grooves on the cell surface of the lysozyme-treated bacteria. The black arrows mark smooth areas between the wrinkles on the cell surface of GMAP2-exposed bacteria. The
white arrowheads indicate non-regular grain and furrows on the cell surface of bacteria incubated with both compounds.
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Fig. 8. Analysis of E. coli cell surface alterations after incubation with G. mellonella lysozyme (1.0 μM) and anionic peptide 2 (1.0 μM). The bacteria were incubated without (control) or in
the presence of lysozyme (1.0 μM), anionic peptide 2 (1.0 μM) or the combination of both compounds as described in Materials and methods and then imaged by AFM. (A) Topography
and deﬂection images of the bacterial cells are presented. The white arrows indicate granular structures on the surface of the lysozyme-treated bacteria. The black arrowsmark the non-
round ends of the GMAP2-exposed cells. The white and black arrowheads indicate the angular ends of cells and surface holes, respectively, visible after incubation of bacteria with the
combination of lysozyme and GMAP2. (B) Topography (a) and 3D (b) images taken from two randomly selected areas on the mica disk and section proﬁles corresponding to the lines
in the images (c) are presented (magniﬁcation 135,000×).
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ordered structures with the presence of cell debris (Fig. 6). Moreover,
the cell surfaces were also altered in comparison to the control cells.
Deep grooves appeared, whereas the small granular structures dis-
appeared from the surface (Fig. 7). Although incubation of the bacteria
with GMAP2 did not cause evident changes in the cell shape, it seemed
to induce a decrease in the turgor as the contours of the individual cells
became less pronounced than those of the control ones (Fig. 6). More-
over, GMAP2 induced cell surface alterations (Fig. 7). The cells were
still covered by wrinkles; however, the cell surface regions between
the wrinkles were much smoother than in the control cells. The wrin-
kles were less numerous and shallower (Fig. 7; see the amplitude and
phase images). After treatment of E. coli with both compounds, many
of the cells were disrupted. The non-disrupted cells seemed to be im-
mersed in an amorphous material, probably a content released from
or the debris of the disrupted ones (Fig. 6). Instead of the small granular
structures, the surface of the non-damaged cells was decorated by non-
regular grain and furrows (Fig. 7). The alterations in the bacteria cell
surface caused by the compounds studied were also reﬂected by differ-
ences of cell section proﬁles, as indicated in Fig. 6B. Although well visi-
ble, the alterations did not inﬂuence much the roughness of E. coli cells.The RMS roughness values of lysozyme- and GMAP2-treated cells were
calculated as 37.63 (±15.59) and 37.33 (±15.86), respectively, whereas
those exposed to both compoundswere calculated as 29.76 (±12.09). In
contrast, the analysis of the force values revealed changes in elasticity
and adhesion properties of the cells after treatment with lysozyme and
GMAP2. Young'smodulus, reﬂecting cell elasticity, decreased signiﬁcant-
ly from 92.67 MPa (±19.12) in the control cells to 78.02 MPa (±7.37;
p=0.023) in E. coli cells exposed to a mixture of lysozyme and GMAP2.
Incubation of E. coli in the presence of lysozyme or GMAP2 did not inﬂu-
ence considerably the cells' elasticity. Young'smodulus valueswere calcu-
lated as 84.08 MPa (±11.08) and 97.5 MPa (±8.05) for lysozyme- and
GMAP2-treated cells, respectively. The measurements of adhesion to the
AFM tip indicated that lysozyme and GMAP2 altered adhesion properties
of E. coli cells. The adhesion force of the control cells was calculated
as 1.71 nN (±0.34), whereas of those treated with lysozyme and
lysozyme-GMAP2 mixture as 3.68 nN (±0.73; p=1.23E−06) and
2.54 nN (±0.58; p=0.001), respectively. GMAP2 alone did not inﬂu-
ence considerably adhesion properties of E. coli cells whichwas reﬂected
by adhesion force calculated as 2.12 nN (±0.37; p=0.064). Interesting-
ly, regular extracellular structureswere noticed in the AFM images of the
bacteria incubated with a mixture of lysozyme and GMAP2. The
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cells (Fig. 6). To determine the nature of these structures, the samples
were imaged using SEM and X-ray analysis was performed (see Subsec-
tion 3.5).
Since the E. coli cells treated with the above-mentioned concentra-
tions of G. mellonella lysozyme and GMAP2 were seriously damaged, a
lower concentration (1.0 μM) of the compounds studied was used in
the following experiments. This facilitated demonstration of subtle al-
terations in the bacterial cell shape and surface occurring under the
inﬂuence of both factors (Fig. 8). The surface of the cells incubated
with 1.0 μM lysozyme was more wrinkled than in the control ones and
irregular granular structures aswell as grooveswere detected. The irreg-
ularities werewell reﬂected by the proﬁles presented in Fig. 8B. The RMS
roughness values of the control and lysozyme-exposed cells were calcu-
lated as 16.60 (±7.77) and 11.13 (±4.44; p=0.0004), respectively.
GMAP2 (1.0 μM) altered the surface of E. coli cells as well, in comparison
to the control ones. The granular structureswere less regular and the fur-
rowswere dipper. The RMS roughness value for the GMAP2-treated cells
was calculated as 8.71 (±2.8; p=0.0002). Moreover, the cell shape was
also affected. Although the cellswere still rod-shaped, their tipswere less
round than in the control ones and they adhered more one to another
(Fig. 8). The alterations of E. coli cell surface caused by lysozyme and
GMAP2 used in combination were more pronounced than the changes
caused by the compounds used alone. First of all, the cells were very
closely packed one next to another, which led to evident changes in
the cell shape (indicated by the arrowheads in Fig. 8A), suggesting a de-
crease in turgor pressure. Moreover, in addition to irregular small granu-
lations covering the cell surface, 100 nm diameter holes were detected
(Fig. 8). The alterations were also reﬂected by changes in the RMS
roughness value, which for these cells was calculated as 11.43 (±4.9;
p=0.001).
The effect of G. mellonella lysozyme (1.0 μM) and AP2 (1.0 μM) on
E. coli cells was also imaged using scanning electronmicroscopy (Fig. 9).
The overall surfaceof cells incubated in the presence of lysozymebecameFig. 9. Scanning electron microscopy images of E. coli cells treated with G. mellonella lyso-
zyme and anionic peptide 2. The bacteriawere incubatedwithout (A; control) or in the pres-
ence of lysozyme (B; 1.0 μM), anionic peptide 2 (C; 1.0 μM) or the combination of both
compounds (D) as described inMaterials andmethods and then imaged by SEM. The arrows
and arrowheads indicate corrugated cell surface and altered structure of tips, respectively.
The asterisks mark bubble-like structures. Single bar=1 μm (magniﬁcation 40,000×).corrugated,whereas the tips of cells treatedwithGMAP2 exhibited an al-
tered structure, in comparison to the control ones. Additionally, small
bubble-like structures were noticed on the slightly corrugated surface
of the bacteria exposed to both compounds (Fig. 9).
To test whether the treatment with G. mellonella lysozyme
and GMAP2 induced the alterations in the cell surface of other
Gram-negative bacteria, similar experiments were performed using
K. pneumoniae (Fig. 10). AFM images revealed that the control cells
had characteristic wrinkles resembling cortex bends with some granu-
lar structures described previously [43]. Treatment of K. pneumoniae
cells with lysozyme (1.0 μM) led to disappearance of the cortex bend-
likewrinkles. Instead, the cell surfacewas coatedwith small, sharp gran-
ules (Fig. 10A). In contrast, the wrinkles and grooves were visible on the
surface of GMAP2-treated cells (1.0 μM); however, their arrangement
and dimensions were different in comparison to the control cells. More-
over, the shapeof some cellswas altered. The cell surface ofK. pneumoniae
incubated in the presence of both G. mellonella lysozyme and GMAP2
underwent considerable alterations, dissimilar to those described above.
The cells became smoother, and the granules and wrinkles were
shallower. The cell surface seemed to be additionally covered with
someamorphousmaterialmasking the inequalities noticedon the surface
of the cells in the other samples. In addition, evident alterations of the cell
shape were observed. The cells were much more convex (ca. 80–120 nm
height) than those in the other samples (ca. 15–40 nm height), probably
as a result of swelling (Fig. 10). The K. pneumoniae cell surface alterations
were well reﬂected by the changes in the RMS roughness values, which
were calculated as 47.11 (±17.61), 25.38 (±15.87; p=0.0006), 25.19
(±14.82; p=0.0003) and 68.53 (±23.74; p=0.005), for the control,
lysozyme-GMAP2-treated cells, and cells incubated with both com-
pounds, respectively.
3.5. X-ray analysis of rectangular structures
In order to understand the nature of the rectangular structures visible
in the AFM images of cells exposed to G. mellonella lysozyme (5.0 μM)
andGMAP2 (5.0 μM)X-ray elementalmicroanalysis under SEMwas per-
formed on the raw material without shadowing (Fig. 11). The compari-
son of the results of the analyses of the bacterial surface (control) and
the rectangular structures revealed that theywere enrichedwith sodium
and chloride. Both these areas demonstrated the relatively high content
of aluminum (Al) and silicon (Si), coming from themica disk, but the dif-
ferential analysis of spectra, after subtraction of the content of the ele-
ments detected in the control areas, indicated that mean content
of sodium and chloride in the rectangular structures was 73.93% and
26.07% (wt.), respectively (Fig. 12). Considering the composition of so-
dium chloride, it can be calculated that about 17% of sodium formed so-
dium chloride crystals in the rectangular structures detected in samples
of bacteria treated with G. mellonella lysozyme and AP2. Hence, the
structures contained about 43% of sodium chloride. The rest of sodium
ions probably formed salts of amino acids.
4. Discussion
In the present study,we demonstrated that the antimicrobial activity
of G. mellonella lysozyme against Gram-negative bacteria increased con-
siderably in the presence of anionic defense peptide GMAP2. Using the
immunoblotting technique, we showed binding of G. mellonella lyso-
zyme to the cell surface of selected Gram-positive and Gram-negative
bacteria. Anti-Gram-positive bacteria activity of lysozyme, based on its
muramidase enzymatic activity, is well documented [31,44]. In our in-
vestigations, G. mellonella lysozyme used in the concentration 0.015 μM
inhibited growth of the Gram-positive bacteria studied, which was ac-
companied by serious alterations of the cell surface and damage to the
cells, as imaged byAFM. Since lysozymebound to theGram-negative bac-
teria, its activity against E. coli andK. pneumoniaewas investigated byus in
more detail. The anti-Gram-negative bacteria activity of G. mellonella
Fig. 10. Analysis of K. pneumoniae cell surface alterations after incubation with G. mellonella lysozyme (1.0 μM) and anionic peptide 2 (1.0 μM). The bacteria were incubated without
(control) or in the presence of lysozyme (1.0 μM), anionic peptide 2 (1.0 μM) or the combination of both compounds as described in Materials and methods and then imaged by
AFM. (A) Topography and deﬂection images of the bacterial cells are presented. The white arrows indicate small, sharp granules on the surface of the lysozyme-treated bacteria. The
black arrows mark the altered layout of wrinkles on the surface of the GMAP2-exposed cells. The white arrowheads indicate the cells with a changed shape noticed after incubation
of bacteria with the combination of lysozyme and GMAP2. (B) Topography (a) and 3D (b) images taken from two randomly selected areas on the mica disk and section proﬁles
corresponding to the lines in the images (c) are presented (magniﬁcation 135,000×).
Fig. 11.Microscopic imaging of the extracellular structures appearing after treatment of E. coli with the combination of G. mellonella lysozyme and anionic peptide 2. The extracel-
lular structures detected in samples of bacteria incubated with lysozyme (5.0 μM) and anionic peptide 2 (5.0 μM)were imaged by AFM (A) and SEM (B). 3D (a), topography (b) and
deﬂection (c) AFM images are presented. Two different magniﬁcations of SEM images, 5000× (d) and 20,000× (e), are demonstrated. The white arrows and the black arrowheads
indicate rectangular structures containing sodium chloride and bacterial cells, respectively.
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Fig. 12. X-raymicroanalysis of the elements of the rectangular structures appearing after treatment ofE. coliwithG.mellonella lysozyme and anionic peptide2. (A) Comparison of
the elements content of the rectangular structures (red line) and the control areas (black line). (B) Sodium and chloride content in the rectangular structures – differential analysis
of the spectra presented in (A).
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parison to the level of the anti-Gram-positive bacteria activity [26]. Two
concentrations of lysozyme, 0.5 μM and 5.0 μM, reﬂecting its concentra-
tions in the hemolymph of naive and bacteria-immunized G. mellonella
larvae, respectively [17], were used in our experiments. Using a perme-
abilization assay it was demonstrated that lysozyme in both concentra-
tions could perforate the cell membrane in E. coli. Surprisingly, addition
of anionic peptide 2 considerably increased the perforation level caused
in E. coli by 0.5 μM lysozyme to almost that detected for 5.0 μM lysozyme.
This result is very meaningful, when one takes into consideration the fact
that both lysozyme and GMAP2 are present in the hemolymph of naive
G. mellonella larvae [17]. The combination of both compounds in the con-
centrations reﬂecting those in non-immune hemolymph caused a con-
siderable increase in the perforation level of Gram-negative
bacteria, indicating that they could be high enough to kill invading
bacterial cells effectively. Hence, thanks to constitutively synthesized
factors present in hemolymph, naive G. mellonella larvae are to some ex-
tent protected against infection caused by Gram-negative bacteria. Our
results clearly suggested a synergistic action of lysozyme and GMAP2
in ﬁghting against pathogens. So far, literature data have indicated only
a possibility of a synergistic action of lysozyme and cationic insect defense
peptides, e.g. cecropins, insect defensins and attacins, against E. coli
[35,36]. A synergistic action of lysozyme and G. mellonella defense pep-
tides against E. coli as well as lysozyme and G. mellonella apoLp-III
against Gram-positive M. luteus was also suggested [33,34]. Similarly,
cationic human defensins HD-1, 2 and 3 as well as bactericidal pep-
tides from hemoglobin (hemocidins) acted synergistically with lyso-
zyme [41,45]. It was also reported that lysozyme decreased MIC for
cationic peptide LL-37/hCAP-18 against Enterococcus faecalis [46]. How-
ever, when anionic peptides of airway surface liquid were tested in the
presence of egg white lysozyme or human neutrophil lysozyme, nosigniﬁcant increase in the antimicrobial activity against Gram-positive
and Gram-negative bacteria was observed at physiological concentra-
tions [47].
Having discovered that G. mellonella GMAP2 and lysozyme could act
in concert against Gram-negative bacteria, we were interested in the
mechanism of their antimicrobial action. A possibility of intermolecular
complex formation between lysozyme and the peptide before their inter-
actionwith bacterial membranewas excluded during gel ﬁltration exper-
iment. However, it is generally assumed that the antimicrobial peptides
existing as disordered structures in aqueous solutions adopt their proper
conformation after exposing to the lipid membrane. The two main con-
formations induced upon membrane binding are α-helix and β-sheet
[5,48–51]. Hence, it cannot be excluded that the contact with bacterial
membrane triggers adopting of a proper conformation of GMAP2 or
eventually modiﬁes its structure, which allows it to interact with lyso-
zyme, resulting in increase of lysozyme antibacterial activity. However,
such possibility is speculative at this moment and requires further
studies.
To provide more insight into antimicrobial action of the studied de-
fense factors, the bacteria incubated in the presence of both compounds
were imaged using AFM and SEM. The analysis of the images suggested
that treatment of the cells with GMAP2 and lysozyme decreased the cell
turgor pressure, as the cells became closely packed and lost their proper
shape. The analysis of the force values conﬁrmed this hypothesis. Young's
modulus of the cells exposed to a mixture of lysozyme and GMAP2 de-
creased signiﬁcantly, whereas at the same time adhesive force between
theAFM tip and cell surface considerably increased. The detected changes
in both parameters reﬂected a decrease in cell wall elasticity, indicating a
decrease in cell turgor pressure.
An exposure of the cells to higher concentrations of lysozyme and
GMAP2 (5.0 μM) resulted in appearance of the rectangular structures
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with destabilization of the osmotic balance affecting the cell volume.
In proper regulation of the cell volume and osmotic balance, the ion
channels (sodium, potassium, calcium, and chloride) and integralmem-
brane proteins allowing movement of ions across the membrane down
their electrochemical gradients are involved. In bacterial cell mem-
branes, different ion channels and substrate transporting systems have
been described. Especially, various sodium–substrate co-transport
systems deliver e.g. amino acids, melibiose, and glutamate into the bac-
terial cell. A gradient of sodium ions provides energy for entry of the
substrate against the concentration gradient [52–54]. It is possible
that crystallization of sodium chloride occurred during preparation of
samples for AFM imaging. However, appearance of the sodium chloride
crystals after treatment of E. coli cells with G. mellonella lysozyme and
GMAP2 suggested that these compounds used in combination could
cause electrolyte imbalance and cell dehydration leading to a decrease
in the cell turgor pressure and, ﬁnally, to disruption of the cells.
It is worth to emphasize that the above-mentioned effects were not
noticed when lysozyme and GMAP2 were used alone against E. coli.
Moreover, GMAP2 did not perforate E. coli cells at all, even at the concen-
tration of 5.0 μM, suggesting that the peptide increased the antibacterial
activity of lysozyme. Interestingly, GMAP2 did not inﬂuence the level of
G.mellonella lysozyme muramidase activity in our assay using M. luteus
lyophilized cells (data not shown). Although GMAP2 did not increase
themuramidase activity, it could alter the E. coli cell surface characteris-
tics facilitating lysozyme binding and access to the peptidoglycan layer.
However, it is known that apart from muramidase, the antibacterial
properties of lysozyme can be attributed to its non-enzymatic activity,
related to the cationic properties of the protein molecule or to its partic-
ular cationic peptide fragments [55,56]. From this point of view, the in-
ﬂuence of GMAP2 on this mode of lysozyme action cannot be excluded
and requires further biochemical investigation.Acknowledgements
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